Who Paid My Doc
John Popovich
Surgical Critical Care Des Moines, IA Medical Doctor
NPI 1487031167 CMS profile 11315916
411 Laurel St Ste 3250, Des Moines, IA 50314
General payments
$5,368
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Popovich of Des Moines, IA is reported in the CMS Open Payments database as having received $5,368 across 20 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 74th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $36 | 2 | |
| 2024 | General | $4,869 | 13 | |
| 2023 | General | $208 | 2 | |
| 2022 | General | $255 | 3 |
Beside peers
- John Popovich
- Surgical Critical Care median
- Middle half of Surgical Critical Care
- National median
In program year 2025, general payments to John Popovich were reported at $36. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.
Show as a table
| Year | John Popovich | Surgical Critical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $161 | $57–$631 | $163 |
| 2020 | $0 | $116 | $33–$383 | $114 |
| 2021 | $0 | $121 | $37–$475 | $132 |
| 2022 | $255 | $163 | $53–$789 | $149 |
| 2023 | $208 | $188 | $67–$1,031 | $160 |
| 2024 | $4,869 | $216 | $80–$1,133 | $164 |
| 2025 | $36 | $231 | $82–$1,489 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 37 billing codesPaid by Medicare
$39,338
Medicare patients
161
Services billed
283
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 46% | |
| Chronic kidney disease | 45% | |
| Diabetes | 42% | |
| Ischemic heart disease | 42% | |
| Atrial fibrillation | 39% | |
| Heart failure | 35% | |
| Depression | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
20 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgical Critical Care in Iowa
Lucy Wibbenmeyer
Surgical Critical Care · Iowa City, IA
Joseph Losh
Surgical Critical Care · Des Moines, IA
Jeffrey Neitzel
Surgical Critical Care · Des Moines, IA
Ea-Sle Chang
Surgical Critical Care · Des Moines, IA
Lawrence Sann
Surgical Critical Care · Des Moines, IA
Michael Devries
Surgical Critical Care · Iowa City, IA
Related records
Surgical Critical Care in Iowa
Practitioners in the same specialty and state, ranked by reported value.
All Surgical Critical Care
Everyone recorded under this specialty, nationwide.
Doctors in Iowa
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.